Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

34,100

Employees34,100

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

34,100

Employees34,100

BMY Key Statistics

Market cap

92.49B

Market cap92.49B

Price-Earnings ratio

18.45

Price-Earnings ratio18.45

Dividend yield

5.38%

Dividend yield5.38%

Average volume

23.29M

Average volume23.29M

High today

$46.18

High today$46.18

Low today

$44.66

Low today$44.66

Open price

$45.25

Open price$45.25

Volume

17.89M

Volume17.89M

52 Week high

$63.33

52 Week high$63.33

52 Week low

$42.96

52 Week low$42.96

BMY News

Nasdaq 1d

BMY November 14th Options Begin Trading

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the November 14th expiration. At Stock Options Channel , our YieldB...

Nasdaq 2d

Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life

Looking at the universe of stocks we cover at Dividend Channel, on 10/3/25, Quest Diagnostics, Inc. (Symbol: DGX), Bristol Myers Squibb Co. (Symbol: BMY), and G...

Simply Wall St 6d

Does Bristol-Myers Squibb’s Slide Present Opportunity as Pharma Tariff Decision Nears?

Thinking about what to do with your Bristol-Myers Squibb shares? You are not alone. The stock is down 2.0% over the past week, and if you stretch that window to...

Analyst ratings

69%

of 29 ratings

Buy

27.6%

Hold

69%

Sell

3.4%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.